Table 3.
Mean changes in the five subthemes of activity pacing (APQ-28) between T1 (baseline), T2 (end of 6 weeks’ treatment) and T3 (3 months’ follow-up)
| Measures | T1 mean (SD) T2 mean (SD) |
T2-T1 mean change (95% CI); effect size(d) | T2 mean (SD) T3 mean (SD) |
T3-T2 mean change (95% CI); effect size(d) | T3 mean T1 mean |
T3-T1 mean change (95% CI); effect size(d) |
| APQ-28 activity adjustment | (n=63) T1 mean=1.73 (0.77) T2 mean=2.43 (0.73) |
0.70 (95% CI=0.48 to 0.91); d=0.91 | (n=51) T2 mean=2.44 (0.72) T3 mean=2.32 (0.90) |
−0.12 (95% CI= −0.36 to 0.11); d=−0.17 | (n=50) T1 mean=1.75 (0.78) T3 mean=2.33 (0.90) |
0.58 (95% CI=0.33 to 0.83); d=0.74 |
| APQ-28 activity planning | (n=65) T1 mean=1.44 (0.95) T2 mean=2.42 (0.87) |
0.99 (95% CI=0.72 to 1.26); d=1.03 | (n=52) T2 mean=2.45 (0.87) T3 mean=2.06 (1.02) |
−0.39 (95% CI= −0.70 to −0.07); d=−0.45 | (n=52) T1 mean=1.42 (0.96) T3 mean=2.06 (1.02) |
0.64 (95% CI=0.36 to 0.92); d=0.67 |
| APQ-28 activity consistency | (n=65) T1 mean=1.82 (0.96) T2 mean=2.65 (0.74) |
0.84 (95% CI=0.60 to 1.07); d=0.86 | (n=52) T2 mean=2.66 (0.71) T3 mean=2.37 (0.72) |
−0.29 (95% CI= −0.54 to −0.04); d=−0.41 | (n=52) T1 mean=1.86 (1.00) T3 mean=2.37 (0.72) |
0.51 (95% CI=0.24 to 0.78); d=0.51 |
| APQ-28 activity acceptance | (n=65) T1 mean=1.87 (0.84) T2 mean=2.55 (0.72) |
0.67 (95% CI=0.46 to 0.89); d=0.81 | (n=52) T2 mean=2.57 (0.73) T3 mean=2.42 (0.95) |
−0.15 (95% CI= −0.38 to 0.08); d=−0.21 | (n=52) T1 mean=1.84 (0.91) T3 mean=2.42 (0.95) |
0.58 (95% CI=0.33 to 0.84); d=0.64 |
| APQ-28 activity progression | (n=65) T1 mean=1.45 (0.88) T2 mean=2.39 (0.89) |
0.94 (95% CI=0.65 to 1.22); d=1.07 | (n=52) T2 mean=2.40 (0.91) T3 mean=2.00 (0.91) |
−0.40 (95% CI= −0.75 to −0.05); d=−0.44 | (n=52) T1 mean=1.45 (0.85) T3 mean=2.00 (0.91) |
0.56 (95% CI=0.24 to 0.87); d=0.65 |
APQ-28, 28-item Activity Pacing Questionnaire.